Specific blockade of Rictor-mTOR association inhibits mTORC2 activity and is cytotoxic in glioblastoma
Benavides-Serrato, Angelica, Lee, Jihye, Holmes, Brent, Landon, Kenna A, Bashir, Tariq, Jung, Michael E, Lichtenstein, Alan, Gera, Joseph
Published in PloS one (28.04.2017)
Published in PloS one (28.04.2017)
Get full text
Journal Article
Correction: Specific blockade of Rictor-mTOR association inhibits mTORC2 activity and is cytotoxic in glioblastoma
Benavides-Serrato, Angelica, Lee, Jihye, Holmes, Brent, Landon, Kenna A, Bashir, Tariq, Jung, Michael E, Lichtenstein, Alan, Gera, Joseph
Published in PloS one (06.02.2019)
Published in PloS one (06.02.2019)
Get full text
Journal Article
Mechanistic Target of Rapamycin (mTOR) Inhibition Synergizes with Reduced Internal Ribosome Entry Site (IRES)-mediated Translation of Cyclin D1 and c-MYC mRNAs to Treat Glioblastoma
Holmes, Brent, Lee, Jihye, Landon, Kenna A., Benavides-Serrato, Angelica, Bashir, Tariq, Jung, Michael E., Lichtenstein, Alan, Gera, Joseph
Published in The Journal of biological chemistry (01.07.2016)
Published in The Journal of biological chemistry (01.07.2016)
Get full text
Journal Article
The protein arginine methyltransferase PRMT5 confers therapeutic resistance to mTOR inhibition in glioblastoma
Holmes, Brent, Benavides-Serrato, Angelica, Saunders, Jacquelyn T., Landon, Kenna A., Schreck, Adam J., Nishimura, Robert N., Gera, Joseph
Published in Journal of neuro-oncology (01.10.2019)
Published in Journal of neuro-oncology (01.10.2019)
Get full text
Journal Article
mTORC2/AKT/HSF1/HuR constitute a feed-forward loop regulating Rictor expression and tumor growth in glioblastoma
Holmes, B, Benavides-Serrato, A, Freeman, R S, Landon, K A, Bashir, T, Nishimura, R N, Gera, J
Published in Oncogene (08.02.2018)
Published in Oncogene (08.02.2018)
Get full text
Journal Article